| Entry |
|
|---|
| Name |
Amrinone (JAN/INN);
Inamrinone (USP);
Amcoral (TN)
|
|---|
| Formula |
C10H9N3O
|
|---|
| Exact mass |
187.0746
|
|---|
| Mol weight |
187.198
|
|---|
| Structure |
     |
|---|
| Activity |
Cardiotonic
|
|---|
| Remark |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CE Phosphodiesterase inhibitors
C01CE01 Amrinone
D00231 Amrinone (JAN/INN); Inamrinone (USP)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases
phosphodiesterase (PDE) III [HSA:5139 5140] [KO:K13296]
Amrinone [ATC:C01CE01]
D00231 Amrinone (JAN/INN); Inamrinone (USP)
 |
|---|
| Other DBs |
CAS: 60719-84-8 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 14
1 C8y C 23.9805 -17.7980
2 C8y C 25.3851 -17.7922
3 C8x C 23.2666 -16.5925
4 C8x C 23.2958 -19.0211
5 C8x C 26.0991 -16.5866
6 C8x C 26.0697 -19.0094
7 C8y C 21.8678 -16.6100
8 N4x N 21.8912 -19.0328
9 C8x C 27.4917 -16.5983
10 C8x C 27.4685 -19.0269
11 C8y C 21.1832 -17.8272
12 N1a N 21.1540 -15.4045
13 N5x N 28.1823 -17.8214
14 O5x O 19.7846 -17.8448
BOND 15
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 2
6 3 7 2
7 4 8 1
8 5 9 2
9 6 10 1
10 7 11 1
11 7 12 1
12 9 13 1
13 11 14 2
14 8 11 1
15 10 13 2
|
|---|
